| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |